International Issues

December 18, 2019
EC Begins Public Consultations on Fitness Check of EU Legislation Regarding Endocrine Disruptors
December 13, 2019
FAQs Regarding Brexit—What Chemical Companies Need To Know
December 9, 2019
Requirements for South Korean Manufacturers and Importers of Chemicals Continue to Change
September 18, 2019
EC Proposes REACH Restriction For PVC Articles Containing Lead And Lead Compounds and Other Recent REACH Developments
August 28, 2019
Australia’s New Scheme for Introducing Industrial Chemicals Will Begin July 1, 2020
July 12, 2019
China Begins Public Consultation on Draft Revision to MEP Order No. 7
July 12, 2019
ECHA’s Management Board Supports Efforts To Improve REACH Authorization And Evaluation and Other Recent REACH Developments
June 27, 2019
China Accepting Nominations of Existing Chemical Substances to Existing Chemical Inventory
June 20, 2019
EC Begins Public Consultation on Fitness Check Roadmap on Endocrine Disruptors
June 12, 2019
BoA Issues Landmark Decision In Data Sharing Dispute and Other Recent REACH Developments
 1 2 3 >  Last › View 10 | 25 | 50 | 100 per page
 
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-557-3800 • 202-557-3836 (fax) | lawbc.com
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy | Attorney Advertising | Trademarks
©2020 Bergeson & Campbell, P.C.
All Rights Reserved.

We are very pleased to offer complimentary subscription to our informative newsletter(s), but we will need to collect some information to do so.

Please carefully read the provisions of the PRIVACY POLICY and the TERMS OF SERVICE ( click to read )

When you opt-in by clicking the button below, you agree to share your USER ID, EMAIL ADDRESS, COMPANY AFFILIATION, and JOB TITLE for the purpose of receiving our emailed newsletter(s).

If you do not accept these terms of use, do not subscribe to our newsletter(s).




I agree to the collection and use of my personal data as described above.


I do not agree to the collection and use of my personal data as described above and therefore agree not to access this subscription form.